RCUSArcus Biosciences, Inc.
30.34USD-0.03%Mkt Cap: 3.86B $P/E: —3d ago
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap3.86B $
Enterprise Value3.29B $
Revenue (TTM)117.00M $
Gross Profit-380.00M $
Net Income (TTM)-353.00M $
Revenue/Share0.9820 USD
Last Price30.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees601
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.84
PEG—
EV/EBITDA-6.92
EV/Revenue28.16
P/S31.73
P/B8.08
EPS (TTM)-3.83
EPS (Forward)-3.34
52W Range
9.81094% of range31.74
52W High31.74 USD
52W Low9.810 USD
Profitability
Gross Margin0.00%
Oper. Margin-234.15%
EBITDA Margin0.00%
Profit Margin-142.91%
ROE-55.94%
ROA-30.99%
Growth
Revenue Growth-74.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-482.00M $
CapEx (TTM)2.00M $
FCF Margin-231.30%
FCF Yield-7.01%
Net Debt-464.00M $
Net Debt/EBITDA0.97
Balance Sheet
Debt/Equity0.18
Current Ratio3.82
Quick Ratio3.75
Book Value/Sh3.654 USD
Cash/Share5.513 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.33 USD
Upside (mean)+26.3%
Target Range23.00 USD – 47.00 USD
$23.00+26.3% to mean$47.00
# Analysts12
Ownership
Shares Out.127.33M
Float90.57M
Insiders28.80%
Institutions74.66%
Short Interest
Short Ratio12.3d
Short % Float16.82%
Short % Out.10.30%
Shares Short13.12M
Short (prev mo.)12.64M
Technical
SMA 5028.16 (+7.7%)
SMA 20024.05 (+26.2%)
Beta0.81
S&P 52W Chg18.16%
Avg Vol (30d)911.16K
Avg Vol (10d)1.23M
Technical Indicators
RSI (14)61.9
MACD0.5133
MACD Signal0.3298
MACD Hist.+0.1834
BB Upper30.61 USD
BB Middle28.60 USD
BB Lower26.60 USD
BB Width14.02%
ATR (14)1.329 USD
Vol Ratio (20d)0.89x